NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $30.6 million in its second quarter.

On a per-share basis, the Newark, California-based company said it had a loss of 50 cents.

The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 50 cents per share.

The biopharmaceutical company posted revenue of $4.2 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX